What is APPA Group?
The APPA Group historically provided pathology services to clients and their patients. However, as of October 31, 2022, the company ceased operations. It arranged for ProPath Laboratories in Dallas to assume its practice, ensuring continuity of service for pathology reports and additional testing. Staff were available to assist clients during this transition period, highlighting a commitment to client care even during operational changes.
How much funding has APPA Group raised?
APPA Group has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in APPA Group
PPP
Public-Private Partnership
What's next for APPA Group?
Given the cessation of operations and the handover to ProPath Laboratories, APPA Group's future strategic direction is now centered on the successful integration of its practice with ProPath. The substantial funding previously raised, totaling $150K, likely supported its operational infrastructure and client service commitments during its active years. The recent strategic investment of $150K may have facilitated this transition or supported other strategic initiatives prior to its operational closure. The focus shifts from expansion to ensuring a seamless continuation of services for its former clientele.
See full APPA Group company page
